201 related articles for article (PubMed ID: 1920361)
21. Demonstration of Ac-Arg-Gly-Asp-Ser-NH2 as an antiaggregatory agent in the dog by intracoronary administration.
Shebuski RJ; Berry DE; Bennett DB; Romoff T; Storer BL; Ali F; Samanen J
Thromb Haemost; 1989 Apr; 61(2):183-8. PubMed ID: 2749593
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of sulfur-free cyclic hexapeptides which contain the RGD sequence and bind to the fibrinogen GP IIb/IIIa receptor. A conformation-based correlation between propensity for imide formation and receptor affinity.
Lender A; Yao W; Sprengeler PA; Spanevello RA; Furst GT; Hirschmann R; Smith AB
Int J Pept Protein Res; 1993 Dec; 42(6):509-17. PubMed ID: 8307682
[TBL] [Abstract][Full Text] [Related]
23. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists.
Zablocki JA; Rico JG; Garland RB; Rogers TE; Williams K; Schretzman LA; Rao SA; Bovy PR; Tjoeng FS; Lindmark RJ
J Med Chem; 1995 Jun; 38(13):2378-94. PubMed ID: 7608903
[TBL] [Abstract][Full Text] [Related]
24. Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.
Bondinell WE; Keenan RM; Miller WH; Ali FE; Allen AC; de Brosse CW; Eggleston DS; Erhard KF; Haltiwanger RC; Huffman WF
Bioorg Med Chem; 1994 Sep; 2(9):897-908. PubMed ID: 7712125
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
Müller G; Gurrath M; Kessler H
J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
[TBL] [Abstract][Full Text] [Related]
26. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
Williams S; Gralnick H
Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
[TBL] [Abstract][Full Text] [Related]
28. Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs.
Mousa SA; Flint S; Lorelli W; Hassell S; Bozarth J; De Grado W; Reilly TM
Thromb Res; 1994 Oct; 76(2):109-19. PubMed ID: 7863463
[TBL] [Abstract][Full Text] [Related]
29. A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody.
Jarrin A; Andrieux A; Chapel A; Buchou T; Marguerie G
FEBS Lett; 1994 Nov; 354(2):169-72. PubMed ID: 7957919
[TBL] [Abstract][Full Text] [Related]
30. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor.
Zablocki JA; Miyano M; Garland RB; Pireh D; Schretzman L; Rao SN; Lindmark RJ; Panzer-Knodle SG; Nicholson NS; Taite BB
J Med Chem; 1993 Jun; 36(13):1811-9. PubMed ID: 8515420
[TBL] [Abstract][Full Text] [Related]
31. Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp.
Egbertson MS; Chang CT; Duggan ME; Gould RJ; Halczenko W; Hartman GD; Laswell WL; Lynch JJ; Lynch RJ; Manno PD
J Med Chem; 1994 Aug; 37(16):2537-51. PubMed ID: 8057299
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
O'Neil KT; Hoess RH; Jackson SA; Ramachandran NS; Mousa SA; DeGrado WF
Proteins; 1992 Dec; 14(4):509-15. PubMed ID: 1438188
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
36. Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis. (II). Its antiplatelet activities.
Satoh T; Yamashita Y; Kamiyama T; Arisawa M
Thromb Res; 1993 Dec; 72(5):401-12. PubMed ID: 8303683
[TBL] [Abstract][Full Text] [Related]
37. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
38. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
39. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
Andronati SA; Karaseva TL; Krysko AA
Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
[TBL] [Abstract][Full Text] [Related]
40. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
Gartner TK; Bennett JS
J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
